- Home
- ATOM vs AVTX Comparison
ATOM vs AVTX Comparison
Compare ATOM & AVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATOM
- AVTX
- Stock Information
- Founded
- ATOM 2001
- AVTX 2011
- Country
- ATOM United States
- AVTX United States
- Employees
- ATOM N/A
- AVTX N/A
- Industry
- ATOM Semiconductors
- AVTX Biotechnology: Pharmaceutical Preparations
- Sector
- ATOM Technology
- AVTX Health Care
- Exchange
- ATOM Nasdaq
- AVTX Nasdaq
- Market Cap
- ATOM 100.9M
- AVTX 90.9M
- IPO Year
- ATOM 2016
- AVTX 2015
- Fundamental
- Price
- ATOM $7.99
- AVTX $9.38
- Analyst Decision
- ATOM Strong Buy
- AVTX Buy
- Analyst Count
- ATOM 1
- AVTX 3
- Target Price
- ATOM $7.00
- AVTX $29.50
- AVG Volume (30 Days)
- ATOM 432.5K
- AVTX 90.5K
- Earning Date
- ATOM 02-11-2025
- AVTX 11-07-2024
- Dividend Yield
- ATOM N/A
- AVTX N/A
- EPS Growth
- ATOM N/A
- AVTX N/A
- EPS
- ATOM N/A
- AVTX N/A
- Revenue
- ATOM $662,000.00
- AVTX $820,000.00
- Revenue This Year
- ATOM N/A
- AVTX N/A
- Revenue Next Year
- ATOM $2,800.00
- AVTX N/A
- P/E Ratio
- ATOM N/A
- AVTX N/A
- Revenue Growth
- ATOM 13140.00
- AVTX N/A
- 52 Week Low
- ATOM $2.31
- AVTX $3.95
- 52 Week High
- ATOM $9.19
- AVTX $34.46
- Technical
- Relative Strength Index (RSI)
- ATOM 71.02
- AVTX 38.65
- Support Level
- ATOM $7.04
- AVTX $8.77
- Resistance Level
- ATOM $7.99
- AVTX $9.82
- Average True Range (ATR)
- ATOM 0.61
- AVTX 0.79
- MACD
- ATOM 0.06
- AVTX -0.03
- Stochastic Oscillator
- ATOM 95.78
- AVTX 18.89
About ATOM Atomera Incorporated
Atomera Inc is engaged in the business of developing, commercializing, and licensing proprietary processes and technologies for the semiconductor industry. The company's technology, named Mears Silicon Technology, or MST, is a thin film of re-engineered silicon, typically 100 to 300 angstroms (or approximately 20 to 60 silicon atomic unit cells) thick. MST can be applied as a transistor channel enhancement to CMOS-type transistors, the most widely used transistor type in the semiconductor industry. The mears silicon technology of the company can be used for applications like Analog, DRAM, FinFET technology, logic and processors, and SRAM.
About AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical stage biotechnology company focused on the treatment of immune dysregulation. The company's lead asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).